This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Berton, G. Articles by Palatini, P. Search for Related Content PubMed PubMed Citation Articles by Berton, G. Articles by Palatini, P. Pubmed/NCBI databases Medline Plus Health Information Heart Attack

(Circulation. 1997;96:3338-3345.)
© 1997 American Heart Association, Inc.

Articles

Albumin Excretion Rate Increases During Acute Myocardial Infarction and Strongly Predicts Early Mortality

Giuseppe Berton, MD; Tiziana Citro, MD; Rosa Palmieri, MD; Stefania Petucco, MD; Renzo De Toni, DBSc; ; Paolo Palatini, MD

From the Divisione di Cardiologia, Ospedale di Conegliano Veneto (G.B.), Divisione di Medicina, Ospedale di Conegliano Veneto (T.C.), Divisione di Medicina, Ospedale di Adria (R.P.), Divisione di Cardiologia, Ospedale di Bassano del Grappa (S.P.), and Clinica Medica 1a, Università di Padova (R. De T., P.P.), Italy.

Correspondence to Prof Paolo Palatini, Clinica Medica 1a, Via Giustiniani 2, 35126 Padova, Italy.

Background This study was undertaken to assess whether albumin excretion rate (AER) increases during acute myocardial infarction (AMI) and whether it predicts in-hospital mortality.

Methods and Results The study was carried out in 496 subjects admitted to hospital for suspected AMI. Of these, 360 had evidence of AMI. The other 136 were studied as control subjects. AER was assessed by radioimmunoassay in three 24-hour urine collections performed on the first, third, and seventh days after admission. Left ventricular ejection fraction was measured by two-dimensional echocardiography in 254 subjects. AER adjusted for several confounders was higher in the AMI than the non-AMI group on the first (69.2±5.2 versus 27.3±8.5 mg/24 h, P<.0001) and third (30.3±2.7 versus 12.5±4.4 mg/24 h, P=.001) days, whereas no difference was present on the seventh day. When the subjects with heart failure were excluded, the difference between the two groups remained significant (first day, P<.0001; third day, P=.001). On the basis of classification of the 26 AMI patients who died in hospital according to whether they had normal AER, microalbuminuria, or overt albuminuria, mortality rate progressively increased with increasing levels of AER (P<.0001). In a Cox's proportional hazards model, AER was a better predictor of in-hospital mortality than Killip class or echocardiographic left ventricular ejection fraction. A cutoff value of 50 mg/24 h for first-day AER and 30 mg/24 h for third-day AER yielded a sensitivity of 92.3% and of 88.5% and a specificity of 72.4% and of 79.3%, respectively, for mortality. Adjusted relative risks for the two cutoff values were 17.3 (confidence limits, 4.6 to 112.7) and 8.4 (confidence limits, 2.4 to 39.3), respectively.

Conclusions These data show that AER increases during AMI and that it yields prognostic information additional to that provided by clinical or echocardiographic evaluation of left ventricular performance.

Key Words: myocardial infarction • heart failure • mortality • microalbuminuria

This article has been cited by other articles:

				M. Cirillo, M. Laurenzi, M. Mancini, A. Zanchetti, and N. G. De Santo Low Muscular Mass and Overestimation of Microalbuminuria by Urinary Albumin/Creatinine Ratio Hypertension, January 1, 2006; 47(1): 56 - 61. [Abstract] [Full Text] [PDF]

				G. Berton and P. Palatini Measurement of albuminuria during acute myocardial infarction and its relation with prognosis Eur. Heart J., June 2, 2005; 26(12): 1242 - 1242. [Full Text] [PDF]

				R. Pedrinelli, G. Dell'Omo, V. Di Bello, G. Pellegrini, L. Pucci, S. Del Prato, and G. Penno Low-Grade Inflammation and Microalbuminuria in Hypertension Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2414 - 2419. [Abstract] [Full Text] [PDF]

				C. Kragelund, O. Snorgaard, L. Kober, B. Bengtsson, M. Ottesen, S. Hojberg, C. Olesen, J.-J. Kjaergaard, J. Carlsen, C. Torp-Petersen, et al. Hyperinsulinaemia is associated with increased long-term mortality following acute myocardial infarction in non-diabetic patients Eur. Heart J., November 1, 2004; 25(21): 1891 - 1897. [Abstract] [Full Text] [PDF]

				L. M. Ruilope, D. J. van Veldhuisen, E. Ritz, and T. F. Luscher Renal function: the Cinderella of cardiovascular risk profile J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1782 - 1787. [Abstract] [Full Text] [PDF]

				R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease Vascular Medicine, November 1, 2001; 6(4): 257 - 264. [Abstract] [PDF]

				G Berton, R Cordiano, R Palmieri, F Cucchini, R de Toni, and P Palatini Microalbuminuria during acute myocardial infarction; a strong predictor for 1-year mortality Eur. Heart J., August 2, 2001; 22(16): 1466 - 1475. [Abstract] [PDF]

				H. C. Gerstein, J. F. E. Mann, Q. Yi, B. Zinman, S. F. Dinneen, B. Hoogwerf, J. P. Halle, J. Young, A. Rashkow, C. Joyce, et al. Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals JAMA, July 25, 2001; 286(4): 421 - 426. [Abstract] [Full Text] [PDF]